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Abstract The release of opioid peptides, gluten exorphins A, 
which have been isolated from the pepsin-thermolysin digest of 
wheat gluten, with gastrointestinal proteases was examined. 
High levels of gluten exorphin A5 (Gly-Tyr-Tyr-Pro-Thr) 
immunoreactive materials were detected in the pepsin-pancreatic 
elastase digest by a competitive ELISA. From this digest, gluten 
exorphin A5, B5 and B4 were isolated. This means that these 
peptides are released in the gastrointestinal tracts after ingestion 
of wheat gluten. The yield of gluten exorphin A5 in the pepsin-
elastase digest was larger than that in the pepsin-thermolysin 
digest. The gluten exorphin A5 sequence is found 15 times in the 
primary structure of the high molecular weight glutenin. The 
region from which gluten exorphin A5 was released by the action 
of pancreatic elastase was identified using synthetic fragment 
peptides. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
We isolated four opioid peptides, G ly -Tyr -Tyr -P ro -Thr , 
G ly -Tyr -Tyr -P ro , Ty r -G ly -Gly -Trp -Leu and T y r - G l y -
Gly-Trp , from the pepsin-thermolysin digest of wheat gluten 
and named them gluten exorphin A5, A4, B5 and B4, respec-
tively [1]. Among them, gluten exorphins A have peculiar 
structures and are rather selective for 5-receptors. Gluten 
exorphin A5 stimulated postprandial insulin release after 
oral administration in rats, and the effect was reversed by 
co-administration of naloxone [2]. However, it was not clear 
whether gluten exorphins A could be released in the gastro-
intestinal tracts. 
Thus, to clarify whether gluten exorphin A5 is released with 
gastrointestinal proteases from wheat gluten, various digests 
were assayed for gluten exorphin A5 immunoreactive materi-
als by a competitive ELISA. In this paper, we report the 
isolation of gluten exorphins A and B from the pepsin-pan-
creatic elastase digest of wheat gluten and the mechanism of 
release of gluten exorphins A. The sequence of this peptide is 
found 15 times in the primary structure of high molecular 
weight glutenin [3]. The 15 regions containing the gluten exor-
phin A5 sequence in wheat glutenin are classified into four 
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HPLC, high-performance liquid chromatography; TFA, trifluoroace-
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groups according to the preceding residues. The region from 
which this peptide was released by the action of pancreatic 
elastase was identified using four synthetic tetradecapeptides. 
2. Materials and methods 
2.1. Chemical and reagents 
Wheat gluten was obtained from Goodman Fielder Mills, Ltd. Pep-
sin, trypsin, chymotrypsin and pancreatin were from Sigma Chemical 
Co. Porcine pancreatic elastase was from Elastin Products Co. Ther-
molysin was from Seikagaku Kougyo Co. Ltd. Naloxone was from 
USPC Inc. Other reagents used were reagent grade or better. 
2.2. Preparation of gluten exorphin A5 antiserum 
Coupling of gluten exorphin A5 to carrier protein was carried out 
by the following procedures. KLH (20 mg) and 7 mg of gluten exor-
phin A5 were dissolved in 2 ml of distilled water. This mixture (pH 7) 
was incubated with 40 mg of l-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide at room temperature for 4 h. The solution was further 
incubated at 4°C overnight and then dialyzed against PBS (pH 7.4) 
at 4°C for 3 days. Gluten exorphin A5-KLH conjugate was emulsified 
in the same amount of Freund's complete adjuvant. A dose corre-
sponding to 1 mg of gluten exorphin A5 was injected intradermally 
into each female rabbit. The immunization was repeated after 4 and 6 
weeks at a dose corresponding to 0.5 mg of the peptide emulsified in 
an incomplete adjuvant. The serum was collected 1 week later. 
2.3. Detection of gluten exorphin A5 immunoreactive materials by a 
competitive ELISA 
To detect gluten exorphin A5 immunoreactive materials in the 
wheat gluten digests, the following competitive ELISA was per-
formed. All procedures were done at room temperature. BSA-gluten 
exorphin A5 conjugates (1 mg/ml in 0.5 M NaHCOs, pH 9.6, con-
taining 0.2% NaN3) were incubated in wells (100 ul/well) of micro-
plates with 96 flat-bottomed wells (NUNC, 43954, Copenhagen, Den-
mark) for 2 h. The unfixed conjugates were removed by washing the 
plates with washing buffer (PBS containing 0.5% Tween 20 and 0.2% 
NaN3). After this washing, blocking solution (1% BSA in PBS con-
taining 0.2% NaN3) was incubated in each well (100 ul/well) for 2 h to 
coat the surface of the well. After the above washing, 50 ul of a 
standard gluten exorphin A5 solution (0.1-100 mM peptide in wash-
ing buffer) or 50 ul of wheat gluten digests (0.1-10 mg/ml digest in 
washing buffer), and 50 ul of the gluten exorphin A5 antiserum 
(1:1000 dilution in washing buffer) was added to each well and their 
mixture was incubated for 2 h to form the gluten exorphin A5-anti-
body complex. After incubation, the wells were washed with washing 
buffer and anti-rabbit IgG-alkaline phosphatase (100 ul) was incu-
bated in each well for 2 h to form the ternary complex of gluten 
exorphin A5-antibody linked with enzyme. After incubation, the wells 
were washed with washing buffer and then 100 ul of 2 g/1 p-vi\Xxo-
phenyl phosphate disodium (Sigma) was added. After incubation for 
20 min, the absorbance at 405 nm was measured with a microtiter 
reader (Nippon Bio-Rad, ELISA Reader Model 2550). 
Preparation of BSA-gluten exorphin A5 conjugate was carried out 
by the following procedure. BSA (30 mg) and 10 mg of gluten exor-
phin A5 were dissolved in 4 ml of PBS. This mixture was incubated 
with 10 ul of 25% glutaraldehyde at room temperature for 2 h and 
then dialyzed against PBS (pH 7.4) at 4°C for 2 days. 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 8 2 9 - 6 
476 S. Fukudome et al.lFEBS Letters 412 (1997) 475^79 
Table 1 
The amount of gluten exorphin A5 immunoreactive materials in the 
digests of wheat gluten determined by a competitive ELISA 
Digests Gluten exorphin A5 
immunoreactive materials 
(umol/g) 
Pepsin N.D.a 
Pepsin-trypsin N.D." 
Pepsin-trypsin-chymotrypsin N.D.a 
Pepsin-pancreatin 8.4 
Pepsin-pancreatic elastase 16.4 
Pepsin-thermolysin 4.0 
"Not detected. 
2.4. Enzymatic digestion of wheat gluten and synthetic glutenin 
fragments 
Wheat gluten (50 mg/ml solution) was digested with pepsin (0.5 mg/ 
ml) in 0.02 N HCl (pH 2.0) for 5 h at 36°C. After digestion, the pH of 
the solution was adjusted with 1 N NaOH to 7.0. The solution was 
then boiled and centrifuged. The peptic digest was further digested 
with trypsin, chymotrypsin, pancreatic elastase, pancreatin or thermo-
lysin (0.5 mg/ml, respectively) for 5 h at 36°C and boiled. The syn-
thetic glutenin fragments (0.5 mM solution, pH 7.0) were digested 
with pepsin or pancreatic elastase (0.07 mg/ml) for 5 h at 36°C and 
boiled. 
2.5. Purification of peptides 
Separation of peptides in the pepsin-pancreatic elastase digest of 
wheat gluten was accomplished by reversed-phase HPLC as described 
previously [1]. Separation of peptides in the digests of synthetic glu-
tenin fragments was accomplished by reversed-phase HPLC on a cy-
anopropyl silica column (Cosmosil 5CN-R, 4.6x250 mm, Nacalai 
Tesque, Inc.). The column was developed with a liner gradient be-
tween 0 and 40% acetonitrile containing 0.05% TFA at 1 ml/min. The 
eluate was monitored at 215 nm. 
2.6. Opioid activity assay 
The opioid activities were measured by the MVD assay as described 
previously [1]. The mouse vas deferens was suspended with 0.2 g 
tension in a magnus tube containing a Mg2+-free Krebs-Ringer so-
lution. Electrical stimulation was given to evoke submaximal contrac-
tion (20-30 V, 1.2 ms, 0.1 Hz). The contraction was recorded through 
an isometric transducer (TB-612T, Nihon Koden). This assay was 
accomplished in the presence of L-leucyl-L-leucine (2 mM), together 
with bestatin (30 uM), thiorphan (0.3 itM) and captopril (10 iiM). 
2.7. Amino acid sequence analyses and peptide synthesis 
The amino acid sequence of the purified peptide was analyzed by a 
477A protein sequencer (Applied Biosystems Inc.). The peptide was 
synthesized by a PS3 peptide synthesizer (Protein Technologies Inc.). 
The peptides were purified by reversed-phase HPLC on an ODS col-
umn. 
3. Results 
3.1. Gluten exorphin A5 immunoreactive materials in wheat 
gluten digests 
The polyclonal gluten exorphin A5 antiserum showed cross-
reactivities with not only gluten exorphin A5 (G ly -Tyr -Tyr -
Pro-Thr ) but also Ty r -Tyr -P ro -Thr , while no cross-reactivity 
with gluten exorphin A4 (Gly-Tyr -Tyr -Pro) (Fig. 1). Gluten 
exorphin A5 immunoreactive materials in various enzymatic 
digests of wheat gluten were measured by a competitive ELI-
SA using this antiserum (Table 1). Gluten exorphin A5 im-
munoreactive materials were recognized in the pepsin- thermo-
lysin digest from which gluten exorphin A5 has been isolated, 
as expected. Among the gastrointestinal proteases digests, 
they were found in the pepsin-pancreatin and pepsin-pancre-
atic elastase digests, but not in the pepsin or pepsin- t rypsin-
chymotrypsin digests. Especially, the amount of gluten exor-
I 1 1 ! 1 
1000 100 10 1 0.1 
Peptide cone. (nM) 
Fig. 1. The standard curves of gluten exorphin A5 and related pep-
tides in a competitive ELISA. The antiserum was diluted at 1000-
fold with PBS containing 0.5% Tween 20 and 0.2% NaN3. Gluten 
exorphin A5 (Gly-Tyr-Tyr-Pro-Thr), - o ; Tyr-Tyr-Pro-Thr, - A - ; 
gluten exorphin A4 (Gly-Tyr-Tyr-Pro), -□-. 
phin A5 immunoreactive materials in the pepsin-pancreatic 
elastase digest was about 4 times as much as that in the 
pepsin-thermolysin digest. However, the opioid activity in 
the pepsin-pancreatic elastase digest was almost the equal to 
that in the pepsin-thermolysin digest on the M V D assay. 
3.2. Isolation of gluten exorphins from the pepsin-pancreatic 
elastase digest 
To quantify individual opioid peptides, the pepsin-pancre-
atic elastase digest was fractionated by reversed-phase H P L C 
on an O D S column. The opioid activities were recovered in 
five fractions (fractions I, II, III, IV and V) (Fig. 2). These 
fractions were further purified by reversed-phase H P L C on 
different columns and the structures of purified peptides 
were analyzed (Table 2). As shown in Table 2, gluten exor-
phins A5 (fraction II-2), B4 (fraction IV-2), B5 (fraction V-2) 
and T y r - T y r - P r o - T h r lacking the N-terminal Gly of gluten 
exorphin A5 (fraction 1-2) were isolated from the pepsin-pan-
creatic elastase digest. Al though the pure peptide was not 
obtained from fraction III because of its weak opioid activity, 
the elution position of fraction III coincided with that of 
authentic gluten exorphin A4. 
The yields of gluten exorphins A and B in the pepsin-elas-
Table 2 
Purification of opioid peptides derived from the pepsin-pancreatic 
elastase digest 
Number of opioid fractions (%; acetonitrile) 
ODSa 
I 
II 
III 
IV 
V 
(22) 
(24) 
(26) 
(30) 
(35) 
PhenethyP 
1-1 (20.0) 
II-1 
III-l 
IV-1 
V-l 
(24.5) 
(26.5) 
(31.5) 
(38.8) 
Cyanopropyl" 
1-2 ( 9.0) 
II-2 (15.0) 
N.D.C 
IV-2 (22.3) 
V-2 (29.0) 
aIn the presence of 0.05% TFA. 
bIn the presence of 10 mM potassium-sodium phosphate buffer (pH 
7.0). 
cNot detected. 
This table shows the number of opioid active fractions and the ace-
tonitrile concentrations in which they were eluated in various re-
versed-phase HPLC. 
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Table 3 
Opioid activities, receptor affinities and yields of opioid peptides in the pepsin-pancreatic elastase and the pepsin-thermolysin digests 
Pepti 
Gly-
Gly-
Tyr-
Tyr-
ides 
Tyr-
-Tyr-
-Tyr-
-Gly-
-Gly-
-Tyr-
-Tyr-
-Tyr-
-Gly-
-Gly-
-Pro-
-Pro-
-Pro 
-Trp-
-Trp 
-Thr 
-Thr 
-Leu 
(Gluten exorphin 
(Gluten exorphin 
(Gluten exorphin 
(Gluten exorphin 
A5) 
A4) 
B5) 
B4) 
IC50 values ;(uM) 
Opioid activities'* 
GPI 
00 
— 
1000 
>1000 
0.05 
1.5 
MVD 
(8) 
800 
60 
70 
0.017 
3.4 
Receptor affinities8 
[3H]DAGO 
00 
— 
700 
>1000 
0.045 
0.17 
[3H]DADLE 
(5) 
— 
1.5 
3.8 
0.005 
0.18 
Yields from the 
Pepsin-elastase 
(ug/g) 
500 
250 
N.D.b 
0.1 
3.0 
digests 
Pepsin-thermolysin 
Oigfe) 
N.D.b 
40 
400 
0.1 
3.0 
*From reference 
bNot detected. 
[!]■ 
tase digest were compared with those in the pepsin-thermoly-
sin digest (Table 3). The yields of gluten exorphins B in both 
digests were the same, while the yields of gluten exorphins A 
were different between both digests. The yield of gluten exor-
phin A5 in the pepsin-pancreatic elastase was about 6 times 
higher than that in the pepsin-thermolysin digest. Gluten 
exorphin A4 was almost negligible in the pepsin-pancreatic 
elastase digest. Moreover, gluten exorphin A5 related peptide, 
Tyr-Tyr-Pro-Thr which has very weak opioid activity existed 
in large quantities in the pepsin-elastase digest. This peptide 
had not been recognized in the pepsin-thermolysin digest. 
3.3. Release of gluten exorphin A5 from synthetic glutenin 
fragments with pancreatic elastase 
Gluten exorphin A5 is an interspersed repeated sequence 
which exists 15 times in the primary structure of the high 
molecular weight glutenin [3]. The amino acids which precede 
the N-terminal Gly of the gluten exorphin A5 sequence are 
Gin, Pro, His and Ser, while only Ser exists next to the 
C-terminal Thr. Therefore, these regions classified into four 
groups as shown in Table 4. Based on the above regards, we 
synthesized four typical glutenin fragments (tetradecapeptides) 
containing gluten exorphin A5 and hydrolyzed them with pep-
sin and pancreatic elastase. The digests of synthetic glutenin 
fragments were fractionated by reversed-phase HPLC on a 
cyanopropyl column and the yield of gluten exorphin A5 in 
each digest was measured (Table 5). Pepsin did not cleave the 
peptide bonds at the N- and C-termini of gluten exorphin A5 
(data not shown). Gluten exorphin A5 was efficiently released 
with pancreatic elastase from the Ser-type fragment peptide in 
which the gluten exorphin A5 sequence is preceded by Ser. In 
addition, small amounts of gluten exorphins A5 and A4 were 
found in the digest of the His-type fragment peptide. Tyr-
Tyr-Pro-Thr was mainly released from the Pro- and Gin-
type fragment peptides. 
4. Discussion 
The present study demonstrates that gluten exorphins A 
and B are released by the action of pepsin and pancreatic 
elastase. Gluten exorphins A and B have been found in the 
digests which were prepared by the further hydrolysis of the 
pepsin digest of wheat gluten with microbial neutral proteases 
such as thermolysin [1]. In the previous paper, we reported 
that gluten exorphin A5 stimulated the postprandial insulin 
release after the oral administration in rats and the effect was 
reversed by co-administration of naloxone [2]. The sequence 
of this peptide is found 15 times in the primary structure of 
high molecular weight glutenin [3]. Therefore, it is an interest-
ing problem whether gluten exorphin A5 is released from 
wheat gluten with gastrointestinal proteases. The similar ques-
tion has been also indicated about the release of P-casomor-
phins and their isolation from casein digests with gastrointes-
tinal proteases has been attempted [4-6]. 
We attempted to detect gluten exorphin A5 immunoreactive 
materials in the gastrointestinal protease digests of wheat glu-
ten by a competitive ELISA using a polyclonal antibody 
which recognizes the C-terminus of gluten exorphin A5. The 
gluten exorphin A5 antiserum showed cross-reactivities with 
not only gluten exorphin A5 but also Tyr-Tyr-Pro-Thr lack-
ing the N-terminal Gly of gluten exorphin A5. Therefore, it is 
regarded that the amount of gluten exorphin A5 immuno-
reactive materials determined in the digest reflects the amount 
of both gluten exorphin A5 and its analogues with common 
C-terminus. Gluten exorphin A5 immunoreactive materials 
were not found in the digests which were hydrolyzed with 
the combination of pepsin, trypsin and chymotrypsin. This 
result coincides with the our previous report that gluten exor-
phin A5 was not isolated from these digests [1]. These were 
detected in the pepsin-pancreatin and pepsin-pancreatic elas-
tase digests. It is considered that its immunoreactive materials 
in the pepsin-pancreatin digest were produced by the action 
of pancreatic elastase, because pancreatic elastase exists in 
Table 4 
Gluten exorphin A5 sequences in the primary structure of high mo-
lecular weight glutenin and typical synthetic glutenin fragments 
Gluten exorphin A5 sequences Synthetic fragments 
-GQGQQGYYPTSPQQ-
-GQGQQGYYPTSLQQ-
-GQGQQGYYPTSLQQ-
-GQGQQGYYPTSPQQ-
-GQGQQGYYPTSLQQ-
GQGQQGYYPTSPQQ 
••EQGQPGYYPTSPQQ" 
••GQGQPGYYPTSSQL-
"GQGQPGYYPTSLQQ-
"GQGQPGYYPTSPQQ-
••GQGQPGYYPTSSQQ-
••GQGQPGYYPTSPLQ-
"GQGQPGYYPTSPQQ-
"GQGQPGYYPTSPLQ-
••GQGQSGYYPTSPQQ-
"GQGQHGYYPTSPQL-
GQGQPGYYPTSPQQ 
GQGQSGYYPTSPQQ 
GQGQHGYYPTSPQL 
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Fig. 2. Reversed-phase HPLC of the pepsin-pancreatin elastase digest on an ODS column. The column was developed using a linear gradient 
of acetonitrile (0^40%) containing 0.05% TFA at a flow rate of 10 ml/min. 
pancreatin. Especially, the amount of gluten exorphin A5 im-
munoreactive materials in the pepsin-pancreatic elastase di-
gest was larger than that in the pepsin-thermolysin digest. 
As shown in Table 2, gluten exorphin A5, B5 and B4 were 
isolated from the pepsin-pancreatic elastase digest. We could 
not obtain the pure peptide from fraction III because of the 
weak opioid activity in this fraction. The retention time of its 
fraction coincided with that of synthetic gluten exorphin A4 
on an ODS column. In addition, a small amount of gluten 
exorphin A4 was isolated from the pancreatic elastase digest 
of synthetic glutenin fragment. It is possible that opioid ac-
tivity in fraction III might be that of gluten exorphin A4. 
Pepsin did not hydrolyze the peptide bonds at the N- and 
C-termini of gluten exorphin A5 of synthetic glutenin frag-
ments. The pretreatment with pepsin might facilitate the re-
lease of gluten exorphin A5 with neutral proteases through 
solubilizing wheat gluten which is insoluble at neutral pH. 
Under the above condition, gluten exorphin A5 was more 
efficiently released from the pepsin-pancreatic elastase digest 
than the pepsin-thermolysin digest. Pancreatic elastase hydro-
lyzes the peptide bonds at the carboxyl sides of small non-
aromatic amino acids such as Gly, Ala and Ser [7]. On the 
other hand, thermolysin favors hydrolyses of the peptide bond 
at the amino sides of hydrophobic amino acids [8]. In the 
primary structure of the high molecular weight glutenin, 
only Ser exists next to the C-terminal Thr of the gluten exor-
phin A5 sequence among 15 sites containing the gluten exor-
phin A5 sequence. The amount of gluten exorphin A5 in the 
pepsin-pancreatic elastase digest is larger than that in the 
pepsin-thermolysin digest. As for the release of C-termini of 
gluten exorphins A, pancreatic elastase exclusively hydrolyzes 
the Thr-Ser bond, while thermolysin hydrolyzes more effi-
ciently Pro-Thr bond than Thr-Ser bond. Among four series 
of typical glutenin fragments (tetradecapeptides) containing 
gluten exorphin A5, gluten exorphin A5 was released quanti-
tatively from the Ser-type glutenin fragment by the action of 
pancreatic elastase. A small amount of gluten exorphin A5 
was also released from the His-type fragment. On the other 
hand, Tyr-Tyr-Pro-Thr was mainly released from the Pro-
and Gin-type fragments. From these results, it is clear that 
gluten exorphin A5 was released from the very limited regions 
in its sequence found 15 times in wheat glutenin by the action 
of pancreatic elastase. If 5 Gin and 8 Pro residues preceding 
the gluten exorphin A5 sequence in wheat glutenin should be 
replaced with Ser residue by protein engineering techniques, 
the release of gluten exorphin A5 with pancreatic elastase 
might be facilitated. 
It has been reported that the oral administration of pepsin 
digest of wheat gluten influenced the regulation of gastroin-
testinal motility and hormone release, especially insulin and 
Table 5 
The yields of YYPT, GYYPT (gluten exorphin A5) and GYYP (gluten exorphin A4) in the pancreatic elastase digests of synthetic glutenin 
fragments 
Synthetic fragments 
GQGQQGYYPTSPQQ 
GQGQPGYYPTSPQQ 
GQGQSGYYPTSPQQ 
GQGQHGYYPTSPQL 
Yields from the digests 
YYPT 
48 
85 
15 
25 
(%; mol/mol) 
GYYPT 
N.D.a 
N.D.a 
84 
3 
GYYP 
N.D.a 
N.D.a 
N.D.a 
5 
"Not detected. 
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these effects were inhibited by naloxone [9-11]. We isolated 
gluten exorphins A and B from the pepsin-pancreatic elastase 
digest of wheat gluten and identified regions which released 
gluten exorphin A5 by the action of pancreatic elastase in this 
study. This result suggests that gluten exorphins A and B 
would be released in vivo by the action of gastrointestinal 
proteases after the ingestion of wheat gluten. Gluten exorphin 
A5 shows the stimulatory effect on postprandial insulin re-
lease by the oral administration and the effect is reversed by 
naloxone [2]. Therefore, it is possible that gluten exorphins A5 
might be closely related to such a physiological function of the 
wheat gluten digests reported previously. 
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